Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,087B 11.45B 10.27B 9.49B 8.6B 16.08B 16.27B 114B 45.16B 570B 42.96B 42.04B 1,807B P/E 2027 *
29.3x
P/E 2028 * 22.3x
Enterprise Value 1,059B 11.15B 10.01B 9.24B 8.38B 15.67B 15.86B 111B 44.01B 555B 41.87B 40.97B 1,761B EV / Sales 2027 *
3.02x
EV / Sales 2028 * 2.63x
Free-Float
69.73%
Yield 2027 *
0.57%
Yield 2028 * 0.64%
1 week+5.12%
Current month+8.95%
1 month+12.24%
3 months+16.62%
6 months+0.59%
Current year-2.07%
1 week 13.06
Extreme 13.055
13.86
1 month 11.99
Extreme 11.99
13.86
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.12% - - 11.41B
+0.22%+3.35%+55.30%+125.65% 1,140B
+0.91%+5.89%+41.14%+80.36% 641B
-0.12%+1.31%+25.62%+97.24% 507B
+0.63%+4.97%+47.12%+68.18% 383B
+0.86%-1.26%+62.10%+34.36% 347B
+1.02%+3.69%+23.73%+51.35% 293B
-0.25%+3.40%+2.31%+23.38% 266B
+0.75%+5.41%+53.53%+66.09% 240B
+0.25%+3.93%+31.54%+102.65% 197B
Average +0.46%+2.92%+38.04%+72.14% 445.98B
Weighted average by Cap. +0.54%+2.98%+42.01%+84.56%

Financials

2027 *2028 *
Net sales 351B 3.7B 3.32B 3.07B 2.78B 5.2B 5.26B 36.75B 14.6B 184B 13.89B 13.59B 584B 394B 4.15B 3.72B 3.44B 3.12B 5.82B 5.89B 41.19B 16.36B 206B 15.56B 15.23B 654B
Net income 36.92B 389M 349M 322M 292M 546M 553M 3.86B 1.53B 19.35B 1.46B 1.43B 61.37B 49.29B 519M 466M 430M 390M 729M 738M 5.16B 2.05B 25.83B 1.95B 1.91B 81.92B
Net Debt -27.73B -292M -262M -242M -219M -410M -415M -2.9B -1.15B -14.54B -1.1B -1.07B -46.1B -51.33B -540M -485M -448M -406M -759M -768M -5.37B -2.13B -26.91B -2.03B -1.99B -85.32B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
28/10/26 USD 13.75 0.00% 4,578,880
26/10/26 USD 13.75 +4.09% 4,121,883
23/10/26 USD 13.21 -0.15% 3,909,244
22/10/26 USD 13.23 +0.30% 3,983,257
21/10/26 USD 13.19 -0.53% 2,114,079
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,305.00INR
Average target price
1,358.95INR
Spread / Average Target
+4.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited